Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persistence of immunity after a 4-dose Sabin strain inactivated poliovirus vaccine schedule
CTR20211723Phase 3Active
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Sep 2021
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Sabin strain inactivated poliovirus vaccine in poliomyelitis, sponsored by Sinovac Biotech Ltd.. Started Sep 2021; status: active.
02
Drugs
Sabin strain inactivated poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on CTR20211723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211723.